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Abstract
Clinical phenotypes of spinocerebellar ataxia type-5 (SCA5) and spectrin-associated autosomal recessive cerebellar ataxia
type-1 (SPARCA1) are mirrored in mice lacking b-III spectrin (b-III-/-). One function of b-III spectrin is the stabilization of the
Purkinje cell-specific glutamate transporter EAAT4 at the plasma membrane. In b-III-/- mice EAAT4 levels are reduced from
an early age. In contrast levels of the predominant cerebellar glutamate transporter GLAST, expressed in Bergmann glia, only
fall progressively from 3 months onwards. Here we elucidated the roles of these two glutamate transporters in cerebellar
pathogenesis mediated through loss of b-III spectrin function by studying EAAT4 and GLAST knockout mice as well as crosses
of both with b-III-/- mice. Our data demonstrate that EAAT4 loss, but not abnormal AMPA receptor composition, in young b-
III-/- mice underlies early Purkinje cell hyper-excitability and that subsequent loss of GLAST, superimposed on the earlier defi-
ciency of EAAT4, is responsible for Purkinje cell loss and progression of motor deficits. Yet the loss of GLAST appears to be in-
dependent of EAAT4 loss, highlighting that other aspects of Purkinje cell dysfunction underpin the pathogenic loss of GLAST.
Finally, our results demonstrate that Purkinje cells in the posterior cerebellum of b-III-/- mice are most susceptible to the com-
bined loss of EAAT4 and GLAST, with degeneration of proximal dendrites, the site of climbing fibre innervation, most pro-
nounced. This highlights the necessity for efficient glutamate clearance from these regions and identifies dysregulation of
glutamatergic neurotransmission particularly within the posterior cerebellum as a key mechanism in SCA5 and SPARCA1
pathogenesis.
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Introduction
Output from the cerebellar cortex sculpts fine control of motor
movements and balance and is derived solely from Purkinje cell
neurons, alterations to which result in ataxia. Cerebellar abnor-
malities may also underlie the pathophysiology in Alzheimer’s
disease (1,2), schizophrenia (3), autism (4–6) and other cognitive
and neuropsychiatric disorders (7–10).
Mutations in the gene encoding b-III spectrin (SPTBN2) lead to
spinocerebellar ataxia type-5 (SCA5) (11) and spectrin-associated
autosomal recessive cerebellar ataxia type-1 (SPARCA1) (12), two
human neurodegenerative diseases involving gait ataxia and cer-
ebellar atrophy. b-III spectrin is highly expressed in the cerebel-
lum and the phenotype of b-III-/- mutant mice mirrors the
clinical phenotypes of SCA5 and SPARCA1 (12,13). Considerable
Purkinje cell dysfunction is detectable in young b-III-/- mutant
mice prior to cell loss, including increased parallel fibre-Purkinje
cell excitatory postsynaptic currents (PF-PC EPSCs) and a 50% re-
duction in EAAT4 protein levels (13). A progressive loss of GLAST
is also seen from 3 months of age (13). EAAT4 and GLAST are the
two principal cerebellar glutamate transporters, and ultrastruc-
tural analysis of Purkinje cells from b-III-/- mice revealing dark
cell degeneration is consistent with cell death occurring from de-
layed glutamate-mediated excitotoxicity (13).
We previously demonstrated that b-III spectrin directly in-
teracts with EAAT4 and stabilizes high levels of expression at
the plasma membrane (14). The early loss of EAAT4 in b-III-/-
mice is, therefore, almost certainly due to loss of the b-III spec-
trin anchor. However, the cellular and molecular mechanisms
responsible for the delayed loss of GLAST in b-III-/- mice are still
to be resolved. The present study uses crosses of ET4-/- and
GLAST-/- knockout mice with b-III-/- mice to dissect the relative
roles of these glutamate transporters in the pathophysiology of
motor deficits. We used these genetic approaches to determine
the mechanisms underlying initial hyper-excitability in b-III-/-
Purkinje cells (13) and identify which factors previously only
correlated with ataxia are directly linked to disease, facilitating
the development of effective therapeutic strategies.
Here we demonstrate that loss of EAAT4 accounts for the ini-
tial hyper-excitability of Purkinje cells lacking b-III spectrin and
that loss of GLAST appears to work synergistically to worsen
motor deficits. Yet the early loss of EAAT4 does not underlie the
subsequent loss of GLAST protein. When levels of both EAAT4
and GLAST are compromised in b-III-/- mice, the proximal den-
drites of Purkinje cells within the posterior cerebellum are the
most vulnerable to degeneration. This highlights the impor-
tance of efficient glutamate clearance in the vicinity of climbing
fibre innervation and identifies this region as an important ther-
apeutic target for SCAs.
Results
EAAT4 loss results in Purkinje cell hyper-excitability
similar to b-III-/- mice
To discern differences in glutamatergic neurotransmission and
investigate the involvement of EAAT4 loss in the previously re-
ported b-III-/- Purkinje cell hyper-excitability (13) we measured
PF-mediated EPSC amplitudes at increasing stimulus intensities,
as widely reported (15–18). This revealed that PF-EPSCs in 6–week
old EAAT4 knockout (ET4-/-) mice were significantly larger at all
stimulus intensities compared to wild type (WT) (P¼ 1.9  10 5
Fig. 1A), similar to b-III-/- mice (13). Moreover, there was no signif-
icant difference in amplitude between ET4-/- cells and b-III-/-/
ET4-/- cells (P¼ 0.646) indicating EAAT4 loss underpins the en-
hanced PF-PC EPSC amplitudes observed in b-III-/- mice (13).
To ascertain whether the increased EPSC amplitudes were a
consequence of pre- or post-synaptic effects paired-pulse facili-
tation was measured by evoking two presynaptic spikes in close
succession (Fig. 1B). This provides an indication of the release
probability of the pre-synaptic cell by comparing the postsynap-
tic response of the second spike to the first spike. No difference
in the paired-pulse facilitation ratio was seen between 6-week
old WT, ET4-/- and b-III-/-/ET4-/- mice demonstrating changes in
presynaptic release probability from parallel fibre terminals are
unlikely to underlie the enhanced EPSC amplitudes in ET4-/- and
b-III-/-/ET4-/- mice (Fig. 1B). Examination of the decay kinetics re-
vealed the single exponential decay time constant of WT
Purkinje cells was similar to the study by Watase et al. (19) for
mature Purkinje cells (14.363.8 (SD)) and no difference was de-
tected between WT, ET4-/- and b-III-/-/ET4-/- animals (Fig. 1C). In
contrast the decay kinetics in GLAST-/- mice had a single expo-
nential decay time constant 36% longer than WT mice
(P¼ 0.018; data not shown). This is in agreement with other
studies (20,21), and further validates our PF-EPSC data.
No difference in AMPA receptor composition in
b-III-/-mice
During normal development in the cortex and hippocampus the
composition of AMPA receptor changes, with calcium perme-
able GluA1-containing receptors present early in development
being replaced during maturation by calcium impermeable
GluA2-containing receptors (22,23). Failure to switch from
GluA1 to GluA2, or to edit GluA2 subunits would result in persis-
tent expression of Ca2þ-permeable AMPA receptors and EPSCs
with larger amplitudes (24–27). Similarly, in the cerebellum it
has been reported that by P30 GluA1 is no longer expressed in
neurons and is exclusively expressed in Bergmann glia (28).
Therefore, to determine whether an abnormal AMPA receptor
composition is involved in the enhanced PF-PC EPSC amplitudes
observed in Purkinje cells from b-III-/- mice we carried out
whole-cell voltage-clamp recordings from 3-week old animals.
Inward rectification, a characteristic of receptors lacking GluA2,
due to their voltage-dependent block by intracellular poly-
amines was not observed for either genotype at 3-weeks of age
(Fig. 2A and B). In addition, equivalent abundance and cellular
distribution of GluA1 immunoreactivity was observed in the
molecular layer of b-III-/- animals when compared to wild type
animals (Pearson’s correlation coefficient (R6SEM) for GluA1
colocalization: with GFAP P7, WT 0.7860.55, b-III-/- 0.7760.54;
P14, WT 0.7560.53, b-III-/- 0.776 0.55; with calbindin P7, WT
0.8260.58, b-III-/- 0.8160.57; P14, WT 0.860.46, b-III-/-
0.8160.47; Fig. 2C). Together, these data reveal no difference in
the expression profile of GluA1 in b-III-/- animals, with normal
edited GluA2-containing receptor compositions in mature b-
III-/- Purkinje cells.
Loss of GLAST accentuates motor deficits in young
b-III-/- animals
Since a progressive loss of GLAST protein was found to correlate
with worsening motor deficits and Purkinje cell loss in b-III-/-
animals (13) we investigated whether loss of GLAST is instru-
mental in disease progression. This was achieved by carrying
out the first longitudinal behaviour analysis of GLAST knockout
mice using gait analysis, rotarod and an elevated beam task.
4449Human Molecular Genetics, 2016, Vol. 25, No. 20 |
There was no difference in hind-limb base width (P¼ 0.618;
Fig. 3A), number of slips off the elevated beam (P¼ 0.907; Fig. 3B)
or ability to stay on rotarod at 3- and 5-rpm (Fig. 3C) in 6- week
old GLAST-/- animals when compared to age-matched WT ani-
mals. The main significant deficit observed in young GLAST-/-
animals, compared to age matched WT mice, is their ability to
remain on the rotarod at 10-rpm (P¼ 0.035, 0.046, 0.039, 0.025,
trial 1–4, respectively; Fig. 3C). However, it may be that young
GLAST-/- animals are slightly poorer at learning motor tasks
than WT animals shown by a potential learning deficit at 3 rpm
(Fig. 3C). By 6-months of age GLAST-/- animals have a signifi-
cantly wider hind-limb base width than when they were
6-weeks old (p¼ 0.01; Fig. 3A) and wider than 6-month old WT
animals (P¼ 0.004). They make a greater number of slips on the
Figure 1. Larger parallel fibre-mediated EPSC amplitude in ET4-/- mice. (A) Top, representative EPSC waveforms at 6 V stimulus and immunoblot analysis for all
genotypes. Bottom, mean PF-PC EPSC amplitudes versus stimulus intensity for 6-week old WT, ET4-/- and b-III-/-/ET4-/- animals. No significant differences detected
between ET4-/- and b-III-/-/ET4-/- across the range of stimulus intensities but both significantly different to WT animals using mixed model ANOVA analysis. (B) Top,
examples of PF-EPSC waveforms for pairs of stimuli at 6 V. Bottom, degree of paired-pulse facilitation. (C) Single exponential decay time constants. All data are
means6SEM, N¼ 3–5, n¼ 11 (b-III-/-/ET4-/-), 13 (WT) and 15 (ET4-/-).
4450 | Human Molecular Genetics, 2016, Vol. 25, No. 20
elevated beam when 6-months old compared to age-matched
WT (P¼ 0.003; Fig. 3B) and to when they were 6-weeks old
(p¼ 0.002). Finally by 7.5-months of age they are worse on the
rotarod at 3-rpm on day 1 and 2 of testing (P¼ 0.035, 0.008, re-
spectively) and never attain WT performance level, on any day of
testing at 10 months of age (P¼ 0.02, 0.0002, 0.005, 0.0002; Fig. 3D).
Moreover, analyses of young b-III-/-/GLASTþ/- animals, aris-
ing from crossing GLAST-/- animals with b-III-/- mice, revealed a
worse performance on the rotarod at 3 –rpm compared to
age-matched WT, b-III-/-, GLAST-/- and b-III-/-/ET4-/- animals
(P¼ 7.73  10 6, 0.013, 8.55  10 7, 0.004; Fig. 4A). Similarly,
young b-III-/-/GLASTþ/- animals had a significantly wider hin-
dlimb base width (P¼ 7.6  10 6, 1.4  10 5, 2.5  10 4, 4 
10 4; Fig. 4B) and made more slips on an elevated beam (P¼ 1.1
 10 5, 3.8  10 4, 8.82  10 7, 0.01; Fig. 4C) than WT, b-III-/-,
GLAST-/- and b-III-/-/ET4-/- mice, respectively. There was also a
significant difference in motor phenotype of young b-III-/-/
GLASTþ/- animals to both young EAAT4þ/- and GLASTþ/- animals
Figure 2. No change in GluA1-containing AMPA receptors in young bIII-/- Purkinje cells. (A) Superimposed synaptic currents evoked at various holding potentials
(-80 toþ60 mV; 20 mV increments). (B) Current-voltage relationship for EPSCs recorded from Purkinje cells with spermine in patch pipette. All data are means6SEM,
N¼3, n¼7 (WT) and 4 (bIII-/-). (C) Midline sagittal cerebellar sections from animals at postnatal day 7 and 14, immunostained with anti-GluA1 antibody. Bar, 50 lm,
N¼3 for both genotypes.
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(data not shown). Finally confocal immunofluorescence micros-
copy confirmed levels of GLAST protein in young b-III-/-/
GLASTþ/- animals were similar to that of GLASTþ/- animals (Fig.
4D). Comparison of double mutant b-III-/-/GLAST-/- animals was
prevented due to non-Mendelian offspring genotypes arising
from genetic crosses and therefore an insufficient number of
animals with this genotype were obtained.
In contrast no difference was observed between the motor
phenotype of young b-III-/- and b-III-/-/ET4-/- mice using rotarod
(P¼ 0.999; Fig. 4A), hindlimb base width (P¼ 0.963; Fig. 4B) and
elevated beam (P¼ 0.974; Fig. 4C) analyses. Moreover hindlimb
base width measurements in 1-year old animals indicated a
similar disease progression in b-III-/-/ET4-/- mice (3.160.17 cm)
to that of b-III-/- animals (3.126 0.11 cm, P¼ 0.919) but an exacer-
bated phenotype in b-III-/-/GLASTþ/- animals (3.6360.13 cm,
P¼ 0.005).
Together, this behavioural data clearly illustrates for the first
time that loss of GLAST results in a progressive ataxic pheno-
type and it provides the first direct evidence that a reduction in
GLAST protein levels acts in synergy with loss-of b-III spectrin
function to accentuate motor decline, and is not simply an in-
consequential side effect.
Loss of GLAST accelerates Purkinje cell loss in young
b-III-/- animals
To determine whether loss of GLAST is also a key factor in the
death of b-III-/- Purkinje cells, we examined the Purkinje cell
density in the posterior cerebellum of 3-month old b-III-/-/
GLASTþ/- mice. The posterior cerebellum was chosen for this
temporal analysis as even at 1-year of age in b-III-/- mice we ob-
serve no significant loss of Purkinje cells within the anterior cer-
ebellum compared to WT (P¼ 0.996; Fig. 5A and B) whereas
significant cell death is evident in the posterior cerebellum
when compared to WT (P¼ 0.029) and to the anterior cerebellum
of b-III-/- mice (P¼ 0.039). Quantification revealed there was cell
loss in 3-month old b-III-/-/GLASTþ/- mice compared to age-
Figure 3. Progressive motor impairment in GLAST-/- mice. (A) Hind limb base width of 6-week and 6-month old animals. (B) Number of hind-limb slips 6-week and
6-month old mice made when crossing narrow, elevated beam. C, Latency of 6-week old animals to fall from rotarod at 3-, 5- and 10-rpm. (D) Latency of 7.5- and
10-month old WT and GLAST-/- animals to fall from rotarod at 3-rpm. All data are means6SEM. N¼14 (WT), 14 (young GLAST-/-), 7 (old GLAST-/-) in all panels.
E, Immunoblot analyses of cerebellar homogenates from 6-week old WT, GLASTþ/- and GLAST-/- animals.
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matched WT animals (P¼ 0.035), whereas no significant loss
was observed for either b-III-/- or GLAST-/- animals (P¼ 0.835,
0.970; Fig. 5C and D). These results again demonstrate a syner-
gistic effect of reduced GLAST levels and loss-of b-III spectrin
function resulting in diminished Purkinje cell survival. We see
no Purkinje cell loss in either EAAT4þ/- or GLASTþ/- animals
(data not shown).
Loss of GLAST is not a downstream consequence of
early EAAT4 loss
The mechanism for loss of GLAST protein in b-III-/- mice is not
known but thought to be dependent on Purkinje cell dysfunc-
tion; immunofluorescence studies within the cerebellum have
so far only shown b-III spectrin to be expressed in Purkinje cells
(13,29). To ascertain whether there is any expression of b-III
spectrin in Bergmann glia, and there is a cell-autonomous effect
of b-III spectrin loss on GLAST protein levels, we carried out
semi-quantitative RT-PCR and immunoblot analysis using ex-
tracts from primary cerebellar glial cultures and total cerebellar
homogenates. No b-III spectrin transcript (Fig. 6A) or protein
(Fig. 6B) was detected in primary cerebellar glial cultures, the
purity of which was confirmed by the low level of GLT1 protein
expression (Fig. 6B), also an astroglial glutamate transporter but
the expression of which is highly-dependent on the co-
culturing with neurons (30–32). These results indicate that b-III
spectrin is unlikely to be expressed in Bergmann glia in vivo and
demonstrate that in b-III-/- animals a non-cell autonomous ef-
fect most likely underlies loss of GLAST in Bergmann glia.
To determine whether the later loss of GLAST is a down-
stream consequence of earlier EAAT4 loss from Purkinje cells,
possibly mediated by excessive activation of Bergmann glial
AMPA receptors (33), we examined GLAST levels in 6-month old
ET4-/- mice by immunoblot analyses. No loss was detected com-
pared to WT animals (P¼ 0.38; Fig. 6C). Furthermore, when
compared to b-III-/- animals no additional loss of GLAST protein
was observed in 6-month old b-III-/-/ET4-/- mice (P¼ 0.84), cor-
roborating the same rate of disease progression observed in b-
III-/- and b-III-/-/ET4-/- animals (Fig. 4). Since the spectrin-based
cytoskeleton has a multitude of functions mediated by interac-
tions with various proteins (34,35) additional downstream con-
sequences of loss-of b-III spectrin function in synaptic and
structural integrity likely underpin the subsequent loss of
GLAST in Bergmann glia.
Dendritic degeneration in b-III-/- animals is greater in
posterior Purkinje cells with proximal dendrites being
the most susceptible
Finally to investigate further the regional difference in Purkinje
cell death in b-III-/- mice (Fig. 5) we filled, by diffusion from a
whole-cell patch pipette, individual Purkinje cells in acute cere-
bellar sagittal slices with a fluorescent dye. Cells were visualized
by confocal microscopy and the dendritic surface area of indi-
vidual Purkinje cells measured from the anterior (lobules II, III,
IV, V) and posterior (VIII, IX, X) lobules (Fig. 7A). This revealed in
6-month old animals a significant difference in the extent of
dendritic degeneration between b-III-/- Purkinje cells from the
Figure 4. Motor decline of bIII-/- animals accelerated by additional early loss of
GLAST. (A) Latency of 6-week-old mice to fall from rotarod at 3-rpm. (B) Hind
limb base width of 6-week-old animals. (C) Number of hind-limb slips 6-week
old mice made when crossing narrow, elevated beam. All data are means6SEM,
N¼14 (WT), 7 (bIII-/-), 14 (GLAST-/-), 8 (bIII-/-/GLASTþ/-), 8 (bIII-/-/ET4-/-). (D)
Coronal sections of posterior cerebellum from 2-month-old mice immunos-
tained with anti-GLAST antibody. Bar, 50lm.
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posterior and anterior lobules (P¼ 0.05) and between posterior
b-III-/- and WT cells (P¼ 0.006) but not between anterior b-III-/-
and WT cells (P¼ 0.248; Fig. 7B and C). However, by 1-year of
age, there is a significant difference in the dendritic surface area
between b-III-/- and WT cells from anterior lobules (60.964.9%
of WT, P¼ 0.025, N¼ 5, n¼ 7 (WT), 9 (b-III-/-) and further degener-
ation of b-III-/- cells from posterior lobules [35.666% of WT,
P¼ 1.5  10  5, N¼ 5, n¼ 12 (WT), 9 (b-III-/-)].
Images of individually filled Purkinje cells were also used
to measure the distance from the cell body to the first branch
point and this revealed that in animals> 6-months of age this
distance was significantly larger in b-III-/- cells from posterior
lobules compared to WT cells (P¼ 4.0  10 5) and b-III-/- cells in
anterior lobules (P¼ 2.4  10  7). However, there was no differ-
ence in distance from the cell body to the first branch point be-
tween WT and b-III-/- cells in anterior lobules (P¼ 0.988; Fig. 7B
and D). The absence of proximal dendrites in b-III-/- Purkinje
cells from posterior lobules was not a developmental defect as
they were present in 6-week old b-III-/- mice (Fig. 7E). Moreover,
some Purkinje cells (3 out of 9 cells) in anterior lobules exhibited
some loss of proximal dendrites at 18-months of age highlight-
ing a progression of proximal dendritic degeneration (Fig. 7F).
Together the data reveal that proximal dendrites are the most
susceptible to degeneration, starting within the posterior cere-
bellum but progressing to the anterior cerebellum, identifying a
novel feature of disease pathology (Fig. 8).
Finally, we previously reported that in acute slices the
spontaneous activity of b-III-/- Purkinje cells were about half
that of WT cells, both at 6-weeks and 6-months of age (13).
However, within this study no distinction was made between
posterior and anterior lobules. In light of our current observa-
tion that the degeneration of the posterior b-III-/- Purkinje cells
Figure 5. Purkinje cell loss in posterior lobules of bIII-/- mice accelerated by additional early loss of GLAST. (A) Coronal cerebellar sections from 1-year-old WT and bIII-/-
mice immunostained with anti-calbindin antibody. (B) Quantification of Purkinje cell density in 1-year-old WT and bIII-/- mice. (C) Representative confocal images,
from coronal sections, of lobules VIII and IX from 3-month-old mice immunostained with anti-calbindin antibody. (D) Quantification of mean Purkinje cell density in
lobules VIII, IX, X and Crus II of hemispheres. All data are means6SEM, N¼ 3 for each genotype. Bar, 50lm.
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is earlier and greater than that of the anterior Purkinje cells we
sought to determine whether there was any variation in the re-
duction of spontaneous activity in the different populations of
b-III-/- Purkinje cells. No significant difference in frequency was
observed within the different populations in young or old
b-III-/- animals (Fig. 7G) and a similar regularity of firing was
observed in all populations (coefficient of variation< 0.2).
Nevertheless, it was cells in anterior lobules from 6-week old
b-III-/- mice, those exhibiting the least amount of degeneration,
that were found to have the highest spontaneous activity
and therefore the closest to that of age-matched WT cells
(41.764.6 Hz, 0.026 0.003 s).
Discussion
This study conclusively demonstrates that loss of EAAT4 under-
pins early Purkinje cell hyper-excitability in b-III-/- animals and
is the first study to directly show that loss of GLAST accentuates
motor deficits and Purkinje cell death, appearing to act in syn-
ergy with loss-of b-III spectrin function. Moreover the posterior
cerebellum appears to be especially vulnerable to the synergis-
tic effect, likely involving the combined loss of functional
EAAT4 and GLAST (Fig. 8). Yet, the observed loss of GLAST in
b-III-/- animals does not appear to arise from the early loss of
EAAT4 protein.
Figure 6. EAAT4 loss does not result in loss of GLAST. (A) Semi-quantitative RT-PCR analysis for bIII-spectrin and GLAST using RNA template extracted from cerebellar
tissue (crb) or primary glial cultures (glia). Amplification of elongation factor (EF1A1) controlled for total template levels. (B) Immunoblot analysis of 10 mg of cerebellar
and primary glial culture homogenate (arrow, full length (FL) bIII-spectrin, lower MW bands degradation products). (C) Top, Immunoblot analyses of cerebellar homoge-
nate from 6-month old WT, ET4-/-, bIII-/- and bIII-/-/ET4-/- animals. Bottom, Densitometry data quantifying GLAST protein levels, normalised to actin and expressed as
percentage of WT levels. N¼4 for each genotype. All data are means6SEM.
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Figure 7. Proximal dendrites of posterior bIII-/- Purkinje cells most vulnerable to dendritic degeneration. (A) Schematic of sagittal section of cerebellar lobules.
(B) Representative confocal images of Purkinje cells filled with Alexa Fluor 568 from anterior (II –V) and posterior (VIII-X) lobules of 6-month and 1-year-old WT and
bIII-/- animals. (C) Quantification of dendritic surface area of individual Purkinje cells from 6-month old WT and bIII-/- mice. N¼3, n¼4 (WT), 6 (bIII-/-) for each region.
(D) Quantification of distance from Purkinje cell soma to first dendritic branch point in animals>6-months of age. N¼9, n¼14 (WT), 18 (bIII-/-). (E) Representative con-
focal images of Purkinje cells filled with Alexa Fluor 568 from posterior (VIII-X) lobules of 6-week old WT and bIII-/- animals. (F) Representative confocal images of
Purkinje cells filled with Alexa Fluor 568 from anterior lobules (II –V) of 18-month- old WT and bIII-/- animals. (G) Spontaneous firing frequency and interspike interval
of Purkinje cells from young [N¼4, n¼ 12 (anterior), 19 (posterior)] and old bIII-/- animals [N¼9, n¼28 (anterior), 30 (posterior)]. All data are means6SEM. Bar, 20 lm.
4456 | Human Molecular Genetics, 2016, Vol. 25, No. 20
Loss of b-III spectrin leads to complete loss of functional
EAAT4 resulting in Purkinje cell hyper-excitability
Several studies, including our own, have shown EAAT4 levels to
be reduced early in various mouse models of ataxia (13,36–38).
For example, we observed loss of EAAT4 in b-III-/- mice, a mouse
model of SCA5/SPARCA1, before any Purkinje cell degeneration
(13). Similarly reduced EAAT4 levels were observed in young
Spnb3-/- mice, another mouse model of SCA5, with EAAT4 accu-
mulating in the cell soma and dendritic shafts (38), a feature re-
ported in SCA5 autopsy tissue (11). Loss of EAAT4 was also
found in a mouse model of spinocerebellar ataxia type I (SCA1)
prior to any sign of disease (36,39) and EAAT4 levels were found
to be decreased in a spontaneous mouse model (staggerer) of
ataxia (37). These correlative findings have long suggested that
EAAT4 loss may play a key role in ataxia but direct evidence cor-
roborating this association has been lacking.
Here, using EAAT4 knockout mice, we have shown that the
greater excitation we observe in young b-III-/- mice are due to
loss of EAAT4. A similar increase in peak amplitude of PFPC-
EPSCs was observed in young ET4-/- mice as seen in b-III-/- mice
(13) and moreover there was no additive effect in b-III-/-/ET4-/-
mice when compared to ET4-/- and b-III-/- mice. Together, these
data provide compelling evidence that the greater excitation
arising from loss-of b-III spectrin function is due to loss of
EAAT4 and reduced post-synaptic glutamate uptake. Moreover,
despite b-III-/- mice still expressing about 50% of WT EAAT4 pro-
tein levels the increase in Purkinje cell excitability is the same
for ET4-/- and b-III-/- animals. There is also no difference in mo-
tor phenotype between b-III-/- and b-III-/-/ET4-/- mice. It would
therefore appear that in the absence of b-III spectrin the re-
maining EAAT4 protein is not functional. This is an important
finding as it suggests that even if levels of EAAT4 could be ele-
vated pharmacologically or through genetic re-introduction it
would be unlikely to lead to any therapeutic benefit as without
the b-III spectrin anchor the EAAT4 protein would not be cor-
rectly targeted or maintained at the plasma membrane.
Our observed change in peak amplitude of PFPC-EPSCs in
ET4-/- mice is in contrast to two earlier studies (40,41). However,
the animals used in each study were of different ages; Nikkuni et
al using 18–22 day old mice (41), Takayusu et al 22-42 day old (40),
while the present study used 42–46 day old mice. Furthermore,
differences in recording conditions (temperature and holding po-
tential) between the three studies also hinder direct comparison
and could account for variations in observations. In addition the
varying molecular composition of Purkinje cells from different
sagittal compartments (42–44) has the possibility of further com-
pounding variability between different data sets.
Loss of b-III spectrin and GLAST act in synergy to
exacerbate motor decline
Similar to EAAT4, correlative findings have also suggested loss of
GLAST may play a role in the progression of ataxia, but again di-
rect evidence has been lacking. Correlative findings include loss
of GLAST and reduced astroglial glutamate uptake when mutant
ataxin-7 is solely expressed in Bergmann glia with this mouse
displaying ataxia and Purkinje cell death (45). Further correlative
evidence comes from conditional ablation of Bergmann glia in
adult mice resulting in ataxia and degeneration of Purkinje cell
dendrites (46) and loss of GLAST observed in mouse models of
SCA1 (47) and SCA5 (13) at later stages of disease.
We have carried out the first longitudinal study using GLAST
knockout mice and have shown that loss of GLAST gives rise to
progressive ataxia. Previously it had been reported that GLAST
deficient mice display mild motor deficits, but the age of mice
was not reported (19). Here we show a mild motor defect in young
(6-weeks of age) GLAST-/- animals but reveal that the motor defi-
cits are progressive, with old animals performing much worse on
all motor tasks. Moreover, through genetic crosses we directly
show for the first time that reducing GLAST levels has a severe
consequence on the severity of ataxia in b-III-/- animals with
young b-III-/-/GLASTþ/- mice displaying a much earlier decline in
motor performance than either b-III-/- or GLAST-/- animals high-
lighting a synergistic effect of reduced GLAST and loss-of b-III
spectrin function, likely due to a combined loss of EAAT4 and
GLAST, the two predominant glutamate transporters in the cere-
bellum. This conclusion is supported by our analysis of young
EAAT4-/-/GLAST-/- double knockouts that show the same level of
motor dysfunction as b-III-/-/GLASTþ/- mice (data not shown).
Survival of b-III-/- Purkinje cells in posterior cerebellum
dependent on high levels of both EAAT4 and GLAST
The fact loss of Purkinje cells was observed within the posterior
cerebellum of young b-III-/-/GLASTþ/- and old b-III-/- animals in-
dicates that these cells are particularly vulnerable to the syner-
gistic effect of loss of GLAST and b-III spectrin function. GLAST
is believed to be present in functional excess throughout the
cerebellum (48). In contrast EAAT4 displays a differential pat-
tern of expression within parasagittal bands with Purkinje cells
Figure 8. Differences in the timeline of degeneration between anterior and posterior cerebellar lobules in a mouse model of SCA5/SPARCA1.
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in posterior regions possessing higher levels of EAAT4 com-
pared to the anterior regions of the cerebellum (42,44,49). It is
therefore Purkinje cells that should normally express high lev-
els of EAAT4 that appear to be more vulnerable to the combined
loss of GLAST and b-III spectrin (hence EAAT4). Of note greater
glutamate release was shown to occur from climbing fibre ter-
minals in zebrin-positive regions, zones of high EAAT4 express-
ing Purkinje cells (50). Purkinje cell proximal dendrites, the site
of climbing fibre innervation, in the posterior cerebellum may
therefore be the most susceptible to degeneration following the
combined loss of the two predominant glutamate transporters,
EAAT4 and GLAST due to higher levels of glutamate exposure. It
is yet to be determined if differences in the functional circuitry
between zebrin-positive and negative bands underlie the selec-
tive progressive Purkinje cell susceptibility.
There is no significant difference in the reduction of sponta-
neous firing rate between b-III-/- Purkinje cells with varying ex-
tents of cell degeneration. This finding indicates that there is no
effect of cell atrophy on reduced voltage-gated sodium channel
density following the loss of b-III spectrin function (13,51), in
contrast to a reported compensatory effect of neuronal atrophy
in a mouse model of SCA1 which restored BK channel density
and intrinsic membrane excitability (52).
The molecular mechanism leading to the later but progres-
sive loss of GLAST in b-III-/- mice is unclear. Identifying this
mechanism will be paramount in the development of an effec-
tive therapy since data from this study directly highlights the
critical role loss of GLAST plays in disease progression.
Relevance of posterior cerebellar pathology
The discovery that the posterior cerebellum is the first area af-
fected pathologically in b-III-/- mice provides additional insight
into disease pathogenesis and possibly the specific cognitive
deficits observed following complete loss of b-III spectrin func-
tion (12). Although there are anatomical differences between
mice and humans with respect to cerebellar input and involve-
ment of cerebellum in non-motor functions (53), if the human
posterior cerebellum is similarly more vulnerable to loss of both
EAAT4 and GLAST the functional connectivity between the pre-
frontal cortex and posterior cerebellum (54,55) would be dis-
rupted in SPARCA1 patients. Of note the posterior cerebellar-
prefrontal circuit is involved in cognitive tasks such as attention
shifting and verbal working memory tasks (56,57) which appear
to be especially impaired in patients with ataxia (58).
In addition the prefrontal cortex and the posterior cerebel-
lum are believed to be significantly affected by ageing (59–61).
The discovery that Purkinje cells within the posterior cerebel-
lum are more sensitive to reduced levels of both EAAT4 and
GLAST protein may also provide mechanistic insight into age-
related decline in motor and cognitive ability. Developing thera-
peutic strategies to target the posterior cerebellum is likely to
prove useful not only in alleviating motor and cognitive deficits
associated with inherited ataxias but may also mitigate the ef-
fects of normal ageing.
Materials and Methods
Animals
All procedures involved in the generation and analysis of mu-
tant mice were carried out according to the United Kingdom
Animals (Scientific Procedures) Act (1986) and other Home
Office regulations under specific-pathogen-free conditions.
GLAST-/-, ET4-/- and b-III-/- mice, all on a C57BL/6 genetic back-
ground, were generated as described previously (13,19,43) and
both sexes were used in all experiments. The genotypes of all
experimental animals were confirmed by PCR analysis on geno-
mic DNA extracted from ear notch biopsies using ChargeSwitch
gDNA tissue kit (Invitrogen, Carlsbad, CA) as described previ-
ously (13) or as follows: for ET4-/- mice a common upstream pri-
mer (50-ttcctgattgctggaaagattctgg-30) and primers specific for the
wild-type allele (50-agttcagggaaaggccataccttgg-30) and the PGK-
neo cassette in the mutant allele (50-ggatcggccattgaacaagatgg-30)
were used for amplification. The 220-bp (from wild-type allele)
and 1200-bp (from targeted allele) PCR products were resolved
by electrophoresis on a 1.6% w/v agarose gel. For GLAST-/- mice
specific primer sets were used for amplification of wild-type al-
lele (50-aagtgcctatccagtccaacga-30; 50-aagaactctctcagcgcttgcc-30)
and mutant allele (50-aatggaaggattggagctacgg-30; 50-ttccagtt-
gaaggctcctgtgg-30). The 214-bp (from wild-type allele) and 362-
bp (from targeted allele) PCR products were resolved by electro-
phoresis on a 1.6% w/v agarose gel. All knockout mice were via-
ble, although pups from GLAST-/- mice were routinely fostered
with CD1 mothers to ensure survival.
Slice electrophysiology
PF-EPSC measurements at a range of stimuli (3-18 V, 200 ls dura-
tion) were recorded at room temperature as previously described
(13) and the amplitudes and decay time constants (tau) of PF-
evoked EPSCs measured using the NeuroMatic analysis program
in IGOR Pro (Wavemetrics, Lake Oswergo, OR). Spontaneous ac-
tion potentials from acute slices were recorded at 30˚C6 2˚C as
previously described (13). Sagittal cerebellar slices (200 mm) from
P16-21 WT and b-III-/- mice were used to determine I/V relation-
ship of PF-EPSCs. Internal solution contained (in mM): 108 Cs
Methanesulfonate, 9 NaCl, 9 HEPES, 1.8 EGTA, 1.8 MgCl2, 0.4
NaGTP, 2 MgATP, 63 sucrose and 5 QX-314, adjusted to pH 7.4
with CsOH. Recordings were made at room temperature and pic-
rotoxin (50lM) was added to the ACSF. Stimulus intensity was
set to evoke PF-EPSCs of approximately 500 pA at Vh -60 mV (7-42
V, 200 ls). Spermine (0.1 mM) was included in the internal solu-
tion to replace dialysed endogenous polyamines. I/V relation-
ships for PF-EPSCs in WT and b-III-/- mice were generated by
averaging 3 EPSCs at each holding potential (-80 mV toþ60 mV in
20 mV increments). Series resistances were<15 MX and were
compensated for by 85%. Data was acquired using pClamp 9
(Molecular Devices, Sunnyvale, CA) and recordings were filtered
at 2 kHz and sampled at 10 kHz. Data analysis was carried out in
Neuromatic, IGOR Pro (Wavemetrics, Lake Oswego, OR) and us-
ing in-house MatLab scripts.
Motor coordination tests
Elevated beam, footprint analysis and rotarod were performed
as previously described (13).
Immunohistochemistry
Brains were removed and immersion-fixed with 4% w/v parafor-
maldehyde in 0.1 M sodium phosphate buffer, pH 7.4 overnight
at 4 C and either embedded in paraffin or cryoprotected by im-
mersion in 0.1 M sodium phosphate buffer (pH 7.4) containing
30% w/v sucrose. Paraffin sections (10 lm-thick), mounted on
poly-L-lysine-coated slides, were immunostained with anti-
GluA1 antibody (Abcam). All other tissues were quick-frozen on
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dry-ice, then 30 lm-thick coronal free-floating cerebellar sec-
tions immunostained with either anti-calbindin (Swant) or anti-
GLAST antibody as described previously (62). All quantification,
carried out blind to genotype, involved counting the number of
Purkinje cells in the anterior (lobules I-V, simplex and crus I)
and posterior cerebellum (lobules VI -IX, crus II and flocculonod-
ular lobe, lobule X) from three sections/animal and the counts
averaged. Data were pooled from GLAST-/- and b-IIIþ/-/GLAST-/-
animals as no phenotype observed in b-IIIþ/- animals (62).
Images were captured with either a Zeiss inverted LSM510 or
Nikon confocal laser scanning microscope and co-localization
analysis carried out using Image J.
Cerebellar astrocyte culture
Primary astrocytes were purified from 6-day old WT mouse cer-
ebella. The cerebella were dissected and incubated in papain for
30 min at 37 C. After trituration in astrocyte media (DMEM high
glucose, 2 mM glutamine, 10% v/v FBS) containing 0.02% w/v
DNase cells were preplated for 20 min on an uncoated dish to
remove contaminant fibroblasts. Unattached cells were trans-
ferred to a dish coated with 0.5 mg/ml of poly-D-Lysine for 1 h to
allow astroglial attachment. Cells were rinsed with PBS to re-
move neurons and were cultured in DMEM with 10% v/v FBS.
Cultures were passaged after 2-3 DIV.
Semiquantitative RT-PCR
Total RNA was extracted from mouse cerebellum or primary glial
cultures using RNeasy Mini kit (Qiagen, Valencia, CA) and RT-PCRs
carried out using One-Step RT-PCR kit (Qiagen) according to man-
ufacturer’s instructions. Primers for RT-PCR reactions were: b-III
spectrin F1 50-atgagcagcactctgtcacccact-30, R7 50-gccaattcttttgcctt
ccacagc-30; GLAST For 50-atgacaaaaagcaacggagaag-30, Rev 50-cta-
catcttggtttcgctgtc-30. Amplification of the ubiquitously expressed
elongation factor alpha was used to control for RNA levels
(Stratagene, La Jolla, CA).
Immunoblotting
Protein extracts were prepared from whole cerebella or primary
glial cultures and processed as previously described (13).
Primary antibodies were goat anti-bIII spectrin (1:1000; Santa
Cruz), rabbit anti-GLAST (1:200), -GLT1 (1:4,000) or mouse anti-
actin, -calbindin (1:1,600; Sigma, St. Louis, MO). Secondary anti-
bodies were HRP-conjugated donkey anti-rabbit IgG, HRP-
conjugated sheep anti-mouse IgG (1:4,000; Amersham
Pharmacia) and HRP-conjugated donkey anti-goat IgG (1:4,000;
Santa Cruz).
Purkinje cell filling
Individual Purkinje cells were filled with 0.02 mM Alexa FluorAR
568 hydrazide (Invitrogen, A-10441) and imaged as described
previously (29). The surface area was quantified using in-house
MatLab scripts and distance to first branch point measured on
z-projections in Image J.
Statistics
EPSC data were analysed using a mixed model ANOVA with
post-hoc Tukey’s HSD for between subjects comparisons. All
other data were assessed either by Kruskal-Wallis or ANOVA
followed by Bonferroni-corrected Mann-Whitney and Tukey’s HSD
post-hoc tests, respectively. Significance was accepted at P-values
of 0.05 or less. N¼number of animals and n¼number of cells.
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